Cited by 705Muscle Physiology and DisordersMuscle metabolism and nutritionNutrition and Health in Aging

The DOI matches its Crossref record; 155 of the 157 references it cites were found in a registry or an index.

Glucocorticoid-induced skeletal muscle atrophy

Schakman, O., Kalista, S., Barbé, C., Loumaye, A., Thissen, J.P.·2013·The International Journal of Biochemistry & Cell Biology

DOI 10.1016/j.biocel.2013.05.036

Open this paper in CoChat — free account

Abstract

Many pathological states characterized by muscle atrophy (e.g., sepsis, cachexia, starvation, metabolic acidosis and severe insulinopenia) are associated with an increase in circulating glucocorticoids (GC) levels, suggesting that GC could trigger the muscle atrophy observed in these conditions. GC-induced muscle atrophy is characterized by fast-twitch, glycolytic muscles atrophy illustrated by decreased fiber cross-sectional area and reduced myofibrillar protein content. GC-induced muscle atrophy results from increased protein breakdown and decreased protein synthesis. Increased muscle proteolysis, in particular through the activation of the ubiquitin proteasome and the lysosomal systems, is considered to play a major role in the catabolic action of GC. The stimulation by GC of these two proteolytic systems is mediated through the increased expression of several Atrogenes ("genes involved in atrophy"), such as FOXO, Atrogin-1, and MuRF-1. The inhibitory effect of GC on muscle protein synthesis is thought to result mainly from the inhibition of the mTOR/S6 kinase 1 pathway. These changes in muscle protein turnover could be explained by changes in the muscle production of two growth factors, namely Insulin-like Growth Factor (IGF)-I, a muscle anabolic growth factor and Myostatin, a muscle catabolic growth factor. This review will discuss the recent progress made in the understanding of the mechanisms involved in GC-induced muscle atrophy and consider the implications of these advancements in the development of new therapeutic approaches for treating GC-induced myopathy. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting.

Integrity signals

Registry

Crossref · 10.1016/j.biocel.2013.05.036

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle
Southgate, R. J., Neill, B., Prelovsek, O., El‐Osta, A., Kamei, Y., Miura, S., Ezaki, O., McLoughlin, T. J., Zhang, W., Unterman, T. G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702039200 · Cited by 112
Retracted
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“…analyses of muscle atrophy due to a variety of wasting diseases are several genes (Atrogin-1, MuRF-1, Cathepsin-L, PDK4, p21, Gadd45, 4E-BP1) controlled by the FOXO transcription factors (Almon et al., 2007; Jagoe et al., 2002; Komamura et al., 2003; Lecker et al., 2004; Waddell et al., 2008).”
Background
Mechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,163
Growth Hormone and the Insulin-Like Growth Factor System in Myogenesis*
Florini, J. R., Ewton, D. Z., & Coolican, S. A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-5-481 · Cited by 1,148
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784
Muscle Protein Breakdown and the Critical Role of the Ubiquitin-Proteasome Pathway in Normal and Disease States
Lecker, S. H., Solomon, V., Mitch, W. E., & Goldberg, A. L. (1999) · Journal of Nutrition · doi:10.1093/jn/129.1.227s · Cited by 742
Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions
Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigaré, R., Zheng, B., Price, S. R., & Mitch, W. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18330 · Cited by 730
The E3 Ligase MuRF1 Degrades Myosin Heavy Chain Protein in Dexamethasone-Treated Skeletal Muscle
Clarke, B. A., Drujan, D., Willis, M. S., Murphy, L. O., Corpina, R. A., Burova, E., Rakhilin, S. V., Stitt, T. N., Patterson, C., Latres, E., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.009 · Cited by 683
Signaling Pathways and Molecular Mechanisms through which Branched-Chain Amino Acids Mediate Translational Control of Protein Synthesis
Kimball, S. R., & Jefferson, L. S. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.227s · Cited by 637
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
Cohen, S., Brault, J. J., Gygi, S. P., Glass, D. J., Valenzuela, D. M., Gartner, C. A., Latres, E., & Goldberg, A. L. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200901052 · Cited by 610
IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1
Sacheck, J. M., Ohtsuka, A., McLary, S. C., & Goldberg, A. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2004 · Cited by 606
Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control
Kamei, Y., Miura, S., SUZUKI, M. T., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Tomoko, H. A. T. A., Matsuda, J., Aburatani, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400674200 · Cited by 588
Insulin-like Growth Factor-1 (IGF-1) Inversely Regulates Atrophy-induced Genes via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Pathway
Latres, E., Amini, A. R., Amini, A. A., Griffiths, J., Martin, F. J., Wei, Y., Lin, H. C., Yancopoulos, G. D., & Glass, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407517200 · Cited by 538
Growth hormone and the insulin-like growth factor system in myogenesis
Florini, J. R. (1996) · Endocrine Reviews · doi:10.1210/er.17.5.481 · Cited by 536
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms
Ferrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522
Crosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal Muscle
Shimizu, N., Yoshikawa, N., Ito, N., Maruyama, T., Suzuki, Y., Takeda, S.-I., Nakae, J., Tagata, Y., Nishitani, S., Takehana, K., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.001 · Cited by 498
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanism
McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M. G., Ling, N., Smith, H., Sharma, M., & Kambadur, R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20757 · Cited by 496
Corticosteroids Contribute to Muscle Weakness in Chronic Airflow Obstruction
Decramer, M., Lacquet, L. M., Fagard, R., & Rogiers, P. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.8025735 · Cited by 481
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression
Ma, K., Mallidis, C., Bhasin, S., Mahabadi, V., Artaza, J., González-Cadavid, N. F., Arias, J., & Salehian, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2002 · Cited by 416
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & González-Cadavid, N. F. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410
The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
Waddell, D. S., Baehr, L. M., van den Brandt, J., Johnsen, S. A., Reichardt, H. M., Furlow, J. D., & Bodine, S. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00646.2007 · Cited by 368
Interaction and functional collaboration of p300 and C/EBPβ
Mink, S., Haenig, B., & Klempnauer, K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6609 · Cited by 346
Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting
Wing, S. S., & Goldberg, A. L. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.4.e668 · Cited by 345
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz‐Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha‐Hikim, I., Hogue, A., Fielder, T. J., & González-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333
Regulation of Muscle Protein Degradation
Lee, S. W., Dai, G., Hu, Z., Wang, X., Du, J., & Mitch, W. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000127211.86206.e1 · Cited by 324
Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle
Amirouche, A., Durieux, A., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X. A., Peinnequin, A., & Freyssenet, D. G. (2008) · Endocrinology · doi:10.1210/en.2008-0959 · Cited by 301
Glucocorticoids and muscle catabolism
Hasselgren, P.-O. (1999) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199905000-00002 · Cited by 297
Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of Nτ-methylhistidine
Tomas, F. M., Munro, H. N., & Young, V. R. (1979) · Biochemical Journal · doi:10.1042/bj1780139 · Cited by 293
Myostatin Gene Deletion Prevents Glucocorticoid-Induced Muscle Atrophy
Gilson, H., Schakman, O., Combaret, L., Lause, P., Grobet, L., Attaix, D., Ketelslegers, J., & Thissen, J. (2006) · Endocrinology · doi:10.1210/en.2006-0539 · Cited by 288
Muscle Cachexia: Current Concepts of Intracellular Mechanisms and Molecular Regulation
Hasselgren, P.-O., & Fischer, J. E. (2001) · Annals of Surgery · doi:10.1097/00000658-200101000-00003 · Cited by 276
Dexamethasone Represses Signaling through the Mammalian Target of Rapamycin in Muscle Cells by Enhancing Expression of REDD1
Wang, H., Kubica, N., Ellisen, L. W., Jefferson, L. S., & Kimball, S. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610023200 · Cited by 262
Hormonal regulation of protein degradation and synthesis in skeletal muscle.
Goldberg, A. L., Tischler, M., Demartino, G., & Griffin, G. E. (1980) · PubMed · Cited by 253
Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids.
Tiao, G. M., Fagan, J. M., Roegner, V., Lieberman, M. A., Wang, J. J., Fischer, J. E., & Hasselgren, P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118421 · Cited by 248
Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment
Crawford, B. A. L., Liu, P. Y., Kean, M. T., Bleasel, J. F., & Handelsman, D. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021827 · Cited by 238
Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids
Baehr, L. M., Furlow, J. D., & Bodine, S. C. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.212845 · Cited by 234
Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice
Mavalli, M. D., DiGirolamo, D. J., Fan, Y., Riddle, R. C., Campbell, K. S., van Groen, T., Frank, S. J., Sperling, M. A., Esser, K. A., Bamman, M. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42447 · Cited by 217
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis
Braun, T. P., Zhu, X., Szumowski, M., Scott, G. D., Grossberg, A. J., Levasseur, P. R., Graham, K., Khan, S., Damaraju, S., Colmers, W. F., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111020 · Cited by 213
Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro
Ma, K., Mallidis, C., Artaza, J., Taylor, W. E., González-Cadavid, N. F., & Bhasin, S. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1128 · Cited by 208
Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice
Hu, Z., Wang, H., Lee, I. H., Du, J., & Mitch, W. E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38770 · Cited by 205
Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice
Porporato, P. E., Filigheddu, N., Reano, S., Ferrara, M., Angelino, E., Gnocchi, V. F., Prodam, F., Ronchi, G., Fagoonee, S., Fornaro, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci39920 · Cited by 194
Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading
Nakao, R., Hirasaka, K., Goto, J., Ishidoh, K., Yamada, C., Ohno, A., Okumura, Y., Nonaka, I., Yasutomo, K., Baldwin, K. M., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01347-08 · Cited by 194
CORTICOSTEROID MYOPATHY: A CLINICAL AND PATHOLOGICAL STUDY
Khaleeli, A. A., Edwards, R. H. T., Gohil, K., McPhail, G., Rennie, M. J., Round, J. M., & Ross, E. J. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb03198.x · Cited by 190
Modulating skeletal muscle mass by postnatal, muscle‐specific inactivation of the myostatin gene
Grobet, L., Pirottin, D., Farnir, F., Poncelet, D. A., Royo, L. J., Brouwers, B., Christians, E., Desmecht, D. J.-M., Coignoul, F., Kahn, R., et al. (2003) · genesis · doi:10.1002/gene.10188 · Cited by 187
Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting
Deval, C., Mordier, S. B., Obled, C., Béchet, D., Combaret, L., Attaix, D., & Ferrara, M. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600143 · Cited by 184
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
Kline, W. O., Panaro, F. J., Yang, H., & Bodine, S. C. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00873.2006 · Cited by 177
11β-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle
Morgan, S., Sherlock, M., Gathercole, L., Lavery, G. G., Lenaghan, C., Bujalska, I. J., Laber, D., Yu, A., Convey, G., Mayers, R. M., et al. (2009) · Diabetes · doi:10.2337/db09-0525 · Cited by 174
Role of leucine in the regulation of mTOR by amino acids: revelations from structure-activity studies.
Lynch, C. J. (2001) · Journal of NutriLife · doi:10.1093/jn/131.3.861s · Cited by 163
Ectopic Expression of Myostatin Induces Atrophy of Adult Skeletal Muscle by Decreasing Muscle Gene Expression
Durieux, A., Amirouche, A., Banzet, S., Koulmann, N., Bonnefoy, R., Pasdeloup, M., Mouret, C., Bigard, X. A., Peinnequin, A., & Freyssenet, D. G. (2007) · Endocrinology · doi:10.1210/en.2006-1500 · Cited by 162
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy
Escolar, D. M., Hache, L. P., Clemens, P. R., Cnaan, A., McDonald, C. M., Viswanathan, V., Kornberg, A. J., Bertoríni, T. E., Nevo, Y., Lotze, T. E., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b164 · Cited by 161
Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1
Polge, C., Heng, A.-É., Jarzaguet, M., Ventadour, S., Claustre, A., Combaret, L., Béchet, D., Matondo, M., Uttenweiler‐Joseph, S., Monsarrat, B., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-180968 · Cited by 157
Role of the Insulin-Like Growth Factor I Decline in the Induction of Atrogin-1/MAFbx during Fasting and Diabetes
Dehoux, M., Beneden, R. V., Pasko, N., Lause, P., Verniers, J., Underwood, L. E., Ketelslegers, J., & Thissen, J. (2004) · Endocrinology · doi:10.1210/en.2004-0406 · Cited by 151
GSK-3β negatively regulates skeletal myotube hypertrophy
Vyas, D. R., Spangenburg, E. E., Abraha, T. W., Childs, T. E., & Booth, F. W. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00049.2002 · Cited by 150
Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling
Kuo, T., Lew, M. J., Mayba, O., Harris, C. A., Speed, T. P., & Wang, J.-C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111334109 · Cited by 148
FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy
Zheng, B., Ohkawa, S., Li, H., Roberts‐Wilson, T. K., & Price, S. R. (2010) · The FASEB Journal · doi:10.1096/fj.09-151480 · Cited by 145
Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle
Löfberg, E., Gutiérrez, A., Wernerman, J., Anderstam, B., Mitch, W. E., Price, S. R., Bergström, J. P., & Alvestrand, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00993.x · Cited by 142
Increased IGF mRNA in Human Skeletal Muscle after Creatine Supplementation
DELDICQUE, L., LOUIS, M., THEISEN, D., NIELENS, H., DEHOUX, M., THISSEN, J.-P., RENNIE, M. J., & FRANCAUX, M. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000162690.39830.27 · Cited by 141
Self-citation
The Coactivator p300 Directly Acetylates the Forkhead Transcription Factor Foxo1 and Stimulates Foxo1-Induced Transcription
Perrot, V., & Rechler, M. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0292 · Cited by 132
Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle
Shah, O. J., Kimball, S. R., & Jefferson, L. S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.1.e76 · Cited by 127
The Orphan Nuclear Receptor, NOR-1, Is a Target of β-Adrenergic Signaling in Skeletal Muscle
Pearen, M. A., Ryall, J. G., Maxwell, M., Ohkura, N., Lynch, G. S., & Muscat, G. E. O. (2006) · Endocrinology · doi:10.1210/en.2006-0447 · Cited by 124
Muscle-specific MicroRNA1 (miR1) Targets Heat Shock Protein 70 (HSP70) during Dexamethasone-mediated Atrophy*
Kukreti, H., Amuthavalli, K., Harikumar, A., Sathiyamoorthy, S., Feng, P. Z., Anantharaj, R., Tan, S. L. K., Lokireddy, S., Bonala, S., Sriram, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390369 · Cited by 124
Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity
Schwartz, C., Schachtrup, K., Mink, S., Schmolke, M., Budde, B., Wenning, D., & Klempnauer, K.-H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg076 · Cited by 122
A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure
Watson, M. L., Baehr, L. M., Reichardt, H. M., Tuckermann, J. P., Bodine, S. C., & Furlow, J. D. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2011 · Cited by 122
Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle
Allen, D. L., & Loh, A. S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00142.2010 · Cited by 119
Identification of Androgen Response Elements in the Insulin-Like Growth Factor I Upstream Promoter
Wu, Y., Zhao, W., Zhao, J., Pan, J., Wu, Q., Zhang, Y., Bauman, W. A., & Cardozo, C. P. (2007) · Endocrinology · doi:10.1210/en.2006-1653 · Cited by 117
Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle
Jefferson, L. S., Fabian, J. R., & Kimball, S. R. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00141-1 · Cited by 116
Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells
Artaza, J. N., Bhasin, S., Mallidis, C., Taylor, W. E., Ma, K., & González-Cadavid, N. F. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10044 · Cited by 115
p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle
Judge, S. M., Sandesara, P. B., Reed, S. A., & Judge, A. R. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00255.2010 · Cited by 114
The deleterious effects of bed rest on human skeletal muscle fibers are exacerbated by hypercortisolemia and ameliorated by dietary supplementation
Fitts, R. H., Romatowski, J. G., Peters, J., Paddon‐Jones, D., Wolfe, R. R., & Ferrando, A. A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00573.2006 · Cited by 113
Inhibition of glycogen synthase kinase-3β activity is sufficient to stimulate myogenic differentiation
van der Velden, J. L. J., LANGEN, R. C. J., KELDERS, M. C. J. M., Wouters, E. F. �., Janssen-Heininger, Y. M. W., & Schols, A. M. W. J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00068.2005 · Cited by 111
Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in human in vitro differentiated macrophages
Huang, Z.-F., Massey, J. B., & Via, D. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00312-3 · Cited by 110
Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16
Imae, M., Fu, Z., Yoshida, A., Noguchi, T., & Kato, H. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300253 · Cited by 110
Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats
Tomas, F. M., Knowles, S. E., Owens, P. C., Chandler, C. S., Francis, G. L., Read, L. C., & Ballard, F. J. (1992) · Biochemical Journal · doi:10.1042/bj2820091 · Cited by 105
USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states
Combaret, L., Adegoke, O. A. J., Bedard, N., Baracos, V. E., Attaix, D., & Wing, S. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00281.2004 · Cited by 104
Acute Treatment with Corticosteroids Decreases IGF-1 and IGF-2 Expression in the Rat Diaphragm and Gastrocnemius
Gayan‐Ramirez, G., Vanderhoydonc, F., Verhoeven, G., & Decramer, M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803021 · Cited by 102
Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin‒proteasome pathway, are increased in patients with lung cancer referred for thoracotomy
Jagoe, R. T., Redfern, C. P. F., Roberts, R. G., Gibson, G. J., & Goodship, T. H. J. (2002) · Clinical Science · doi:10.1042/cs1020353 · Cited by 102
Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism
Alamdari, N., Aversa, Z., Castillero, E., Gurav, A., Petkova, V., Tizio, S., & Hasselgren, P.-O. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.154 · Cited by 99
Branched‐chain amino acids protect against dexamethasone‐induced soleus muscle atrophy in rats
Yamamoto, D., Maki, T., Herningtyas, E. H., Ikeshita, N., Shibahara, H., Sugiyama, Y., Nakanishi, S., Iida, K., Iguchi, G., Takahashi, Y., et al. (2010) · Muscle & Nerve · doi:10.1002/mus.21621 · Cited by 96
Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm
Dekhuijzen, P. N. R., Gayan‐Ramirez, G., Bisschop, A., de Bock, V., Dom, R., & Decramer, M. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.78.2.629 · Cited by 96
Insulin-Like Growth Factor-I Gene Transfer by Electroporation Prevents Skeletal Muscle Atrophy in Glucocorticoid-Treated Rats
Schakman, O., Gilson, H., de Coninck, V., Lause, P., Verniers, J., Havaux, X., Ketelslegers, J., & Thissen, J. (2005) · Endocrinology · doi:10.1210/en.2004-1594 · Cited by 95
Myofibrillar protein synthesis in myostatin-deficient mice
Welle, S. L., Bhatt, K. S., & Pinkert, C. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2005 · Cited by 94
Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy
Verhees, K. J. P., Schols, A. M. W. J., KELDERS, M. C. J. M., den Kamp, C. M. O., van der Velden, J. L. J., & LANGEN, R. C. J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00520.2010 · Cited by 90
Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity
Wang, X. H., Zhang, L., Mitch, W. E., LeDoux, J. M., Hu, J., & Du, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041707 · Cited by 89
Corticosteroids and skeletal muscle function in cystic fibrosis
Barry, S. C., & Gallagher, C. G. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00506.2002 · Cited by 89
Branched Chain Amino Acids Activate Messenger Ribonucleic Acid Translation Regulatory Proteins in Human Skeletal Muscle, and Glucocorticoids Blunt This Action1
Liu, Z., Jahn, L. A., Long, W., Fryburg, D. A., Wei, L., & Barrett, E. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7481 · Cited by 87
C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle
Penner, G. C., Gang, G., Sun, X., Wray, C. J., & Hasselgren, P. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00512.2001 · Cited by 85
Role of Akt/GSK-3β/β-Catenin Transduction Pathway in the Muscle Anti-Atrophy Action of Insulin-Like Growth Factor-I in Glucocorticoid-Treated Rats
Schakman, O., Kalista, S., Bertrand, L., Lause, P., Verniers, J., Ketelslegers, J. M., & Thissen, J. (2008) · Endocrinology · doi:10.1210/en.2008-0439 · Cited by 83
REDD1 Is a Major Target of Testosterone Action in Preventing Dexamethasone-Induced Muscle Loss
Wu, Y., Zhao, W., Zhao, J., Zhang, Y., Qin, W., Pan, J., Bauman, W. A., Blitzer, R. D., & Cardozo, C. P. (2009) · Endocrinology · doi:10.1210/en.2009-0530 · Cited by 81
Specific Increase in p85α Expression in Response to Dexamethasone Is Associated with Inhibition of Insulin-like Growth Factor-I Stimulated Phosphatidylinositol 3-Kinase Activity in Cultured Muscle Cells
Giorgino, F., Pedrini, M. T., Matera, L., & Smith, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7455 · Cited by 80
Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF‐1 – implications for steroid‐induced myopathy
Inder, W. J., Jang, C., Obeyesekere, V. R., & ALFORD, F. P. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03683.x · Cited by 78
Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol
Awede, B. L., Thissen, J., & Lebacq, J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e31 · Cited by 78
Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids
Shah, O. J., Kimball, S. R., & Jefferson, L. S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470389 · Cited by 75
Glucocorticoid effects on insulin- and IGF-I-regulated muscle protein metabolism during aging
Dardevet, D. P., Sornet, C., Savary‐Auzeloux, I., Debras, E., Patureau-Mirand, P., & Grizard, J. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560083 · Cited by 75
Role of Protein Synthesis in the Inhibitory Action of Adrenal Steroid Hormones on Amino Acid Transport by Muscle1
Kostyo, J. L., & Redmond, A. F. (1966) · Endocrinology · doi:10.1210/endo-79-3-531 · Cited by 73
Effects of Acute Administration of Corticosteroids during Mechanical Ventilation on Rat Diaphragm
Maes, K., Testelmans, D., Cadot, P., DeRuisseau, K. C., Powers, S. K., Decramer, M., & Gayan‐Ramirez, G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-296oc · Cited by 72
Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor
Zhao, W., Qin, W., Pan, J., Wu, Y., Bauman, W. A., & Cardozo, C. P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.123 · Cited by 71
Acetylation and deacetylation—novel factors in muscle wasting
Alamdari, N., Aversa, Z., Castillero, E., & Hasselgren, P.-O. J. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.019 · Cited by 71
Differential Gene Expression in the Rat Skeletal and Heart Muscle in Glucocorticoid-Induced Myopathy: Analysis by Microarray
Komamura, K., Shirotani-Ikejima, H., Tatsumi, R., Tsujita-Kuroda, Y., Kitakaze, M., Miyatake, K., Sunagawa, K., & Miyata, T. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1027352703783 · Cited by 70
Modulations of Muscle Protein Metabolism by Branched-Chain AminoAcids in Normal and Muscle-Atrophying Rats,
Kobayashi, H., Kato, H., Hirabayashi, Y., Murakami, H., & Suzuki, H. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.234s · Cited by 70
The Effect of Glutamine on Prevention of Glucocorticoid-Induced Skeletal Muscle Atrophy Is Associated with Myostatin Suppression
Salehian, B., Mahabadi, V., Bilas, J., Taylor, W. E., & Ma, K. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.009 · Cited by 69
Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells.
Frost, R. A., & Lang, C. H. (2003) · PubMed · Cited by 67
Effects of a Novel Selective Androgen Receptor Modulator on Dexamethasone-Induced and Hypogonadism-Induced Muscle Atrophy
Jones, A. J., Hwang, D., Narayanan, R., Miller, D. D., & Dalton, J. T. (2010) · Endocrinology · doi:10.1210/en.2010-0150 · Cited by 67
Clenbuterol antagonizes glucocorticoid‐induced atrophy and fibre type transformation in mice
Pellegrino, M. A., D’Antona, G., Bortolotto, S. K., Boschi, F., Pastoris, O., Bottinelli, R., Polla, B., & Reggiani, C. (2003) · Experimental Physiology · doi:10.1113/expphysiol.2003.002609 · Cited by 65
Expression of β-catenin is necessary for physiological growth of adult skeletal muscle
Armstrong, D., Wong, V. L., & Esser, K. A. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00644.2005 · Cited by 63
GSK-3β inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes
Evenson, A. R., Fareed, M. U., Menconi, M. J., Mitchell, J. C., & Hasselgren, P.-O. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.06.002 · Cited by 62
The effect of interleukin-1α and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle
Zamir, O., Hasselgren, P.-O., von Allmen, D., & Fischer, J. E. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90045-n · Cited by 57
Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle
Crossland, H., Constantin‐Teodosiu, D., Greenhaff, P. L., & Gardiner, S. M. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.183699 · Cited by 56
Effects of leucine supplementation and resistance exercise on dexamethasone-induced muscle atrophy and insulin resistance in rats
Nicastro, H., Zanchi, N. E., da Luz, C. R., de Moraes, W. M. A. M., de Souza, P. R. M., Filho, M. A. D. S., Chaves, D. F. S., Medeiros, A., Brum, P. C., Dardevet, D. P., et al. (2011) · Nutrition · doi:10.1016/j.nut.2011.08.008 · Cited by 54
Insulin-like growth factor I prevents corticosteroid-induced diaphragm muscle atrophy in emphysematous hamsters
Fournier, M., Huang, Z.-S., Li, H., Da, X., Cercek, B., & Lewis, M. I. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00177.2002 · Cited by 53
Glutamine supplementation promotes anaplerosis but not oxidative energy delivery in human skeletal muscle
Bruce, M., Constantin‐Teodosiu, D., Greenhaff, P. L., Boobis, L., Williams, C., & Bowtell, J. L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.4.e669 · Cited by 53
Protein Breakdown in Muscle from Burned Rats Is Blocked by Insulin-Like Growth Factor I and Glycogen Synthase Kinase-3β Inhibitors
Fang, C., Li, B.-G., James, J. H., King, J.-K., Evenson, A. R., Warden, G. D., & Hasselgren, P.-O. (2005) · Endocrinology · doi:10.1210/en.2004-0869 · Cited by 52
Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens
Almon, R. R., DuBois, D. C., Yao, Z., Hoffman, E. P., Ghimbovschi, S. D., & Jusko, W. J. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2006 · Cited by 52
Glucocorticoids modulate amino acid-induced translation initiation in human skeletal muscle
Liu, Z., Li, G., Kimball, S. R., Jahn, L. A., & Barrett, E. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00457.2003 · Cited by 51
Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent
Yang, H., Wei, W., Menconi, M. J., & Hasselgren, P.-O. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00230.2006 · Cited by 51
Mechanisms Involved in 3′,5′-Cyclic Adenosine Monophosphate-Mediated Inhibition of the Ubiquitin-Proteasome System in Skeletal Muscle
Gonçalves, D. A. P., Lira, E. C., Baviera, A. M., Cao, P., Zanon, N. M., Arany, Z. P., Bedard, N., Tanksale, P., Wing, S. S., Lecker, S. H., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0428 · Cited by 51
Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration
Cho, J. E., Fournier, M., Da, X., & Lewis, M. I. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00704.2009 · Cited by 50
Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats
Menezes, L. G., Sobreira, C., Neder, L., Rodrigues, A. L., & Martínez, J. A. B. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01188.2005 · Cited by 50
Glutamine prevents downregulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids
Hickson, R. C., Czerwinski, S. M., & Wegrzyn, L. E. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.4.e730 · Cited by 50
Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPβ in cultured myotubes
Yang, H., Menconi, M. J., Wei, W., Petkova, V., & Hasselgren, P. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20371 · Cited by 49
Expression of the Muscle Atrophy Factor Muscle Atrophy F-Box Is Suppressed by Testosterone
Zhao, W., Pan, J., Wang, X., Wu, Y., Bauman, W. A., & Cardozo, C. P. (2008) · Endocrinology · doi:10.1210/en.2008-0664 · Cited by 49
Skeletal Muscle 11beta-HSD1 Controls Glucocorticoid-Induced Proteolysis and Expression of E3 Ubiquitin Ligases Atrogin-1 and MuRF-1
Biedasek, K., Andres, J., Mai, K., Adams, S., Spuler, S., Fielitz, J., & Spranger, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016674 · Cited by 49
Myostatin inactivation increases myotube size through regulation of translational initiation machinery
Rodriguez, J., Vernus, B., Toubiana, M., Jublanc, É., Tintignac, L. A. J., Leibovitch, S. A., & Bonnieu, A. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23280 · Cited by 49
β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy
Aversa, Z., Alamdari, N., Castillero, E., Muscaritoli, M., Fanelli, F. R., & Hasselgren, P.-O. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.029 · Cited by 48
Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3β and PI3K/Akt/mTOR-dependent mechanisms
Li, B.-G., Hasselgren, P.-O. J., & Fang, C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.008 · Cited by 48
Multifaceted Role of Insulin-Like Growth Factors and Mammalian Target of Rapamycin in Skeletal Muscle
Frost, R. A., & Lang, C. H. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.012 · Cited by 47
Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone
Agbenyega, E. T., & Wareham, A. C. (1992) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(92)90026-m · Cited by 43
Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy people
Short, K. R., Bigelow, M. L., & Nair, K. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00345.2009 · Cited by 43
Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal muscles
Uozumi, Y., Ito, T., Hoshino, Y., Mohri, T., Maeda, M., Takahashi, K., Fujio, Y., & Azuma, J. (2006) · Biochemical Journal · doi:10.1042/bj20051303 · Cited by 42
C1-Ten Is a Protein Tyrosine Phosphatase of Insulin Receptor Substrate 1 (IRS-1), Regulating IRS-1 Stability and Muscle Atrophy
Koh, A., Lee, M. N., Yang, Y. R., Jeong, H., Ghim, J., Noh, J., Kim, J. J., Ryu, D., Park, S., Song, P., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01447-12 · Cited by 42
Glucocorticoid excess induces a prolonged leucine resistance on muscle protein synthesis in old rats
Rieu, I., Sornet, C., Grizard, J., & Dardevet, D. P. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.005 · Cited by 41
Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin‒proteasome pathway, are increased in patients with lung cancer referred for thoracotomy
Jagoe, R. T., Redfern, C. P. F., Roberts, R. G., et al. (2002) · Clinical Science · doi:10.1042/cs20010270 · Cited by 41
Effects of Cortisol and Dexamethasone on Insulin Signalling Pathways in Skeletal Muscle of the Ovine Fetus during Late Gestation
Jellyman, J. K., Martin‐Gronert, M. S., Cripps, R. L., Giussani, D. A., Ozanne, S. E., Shen, Q. W., Du, ‬., Fowden, A. L., & Forhead, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052363 · Cited by 37
Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats
Roy, B. D., Bourgeois, J. M., Mahoney, D. J., & Tarnopolsky, M. A. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-129 · Cited by 34
Alanyl-glutamine prevents muscle atrophy and glutamine synthetase induction by glucocorticoids
Hickson, R. C., Wegrzyn, L. E., Osborne, D. F., & Karl, I. E. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.5.r1165 · Cited by 32
Effects of creatine supplementation on muscle wasting and glucose homeostasis in rats treated with dexamethasone
Nicastro, H., Gualano, B., de Moraes, W. M. A. M., Painelli, V. D. S., da Luz, C. R., Costa, A. D. S., Guimarães, F. D. S., Medeiros, A., Brum, P. C., & Lancha, A. H. (2011) · Amino Acids · doi:10.1007/s00726-011-0871-9 · Cited by 31
Assessing acetylation of NF-κB
Chen, L., & Greene, W. C. (2005) · Methods · doi:10.1016/j.ymeth.2005.03.011 · Cited by 31
Respiratory Muscle Strength in Cushing's Syndrome
MILLS, G. H., Kyroussis, D., JENKINS, P., Hamnegård, C., Polkey, M. I., Wass, J. A. H., BESSER, G. M., Moxham, J., & Green, M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9810028 · Cited by 30
Prednisolone-Induced Muscle Dysfunction Is Caused More by Atrophy than by Altered Acetylcholine Receptor Expression
Shin, Y. S., Fink, H., Khiroya, R., Ibebunjo, C., & Martyn, J. A. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200008000-00017 · Cited by 30
Anabolic steroids in part reverse glucocorticoid-induced alterations in rat diaphragm
van Balkom, R. H. H., Dekhuijzen, P. N. R., Folgering, H. T. M., Veerkamp, J. H., van Moerkerk, H. T. B., Fransen, J. A. M., & van Herwaarden, C. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.84.5.1492 · Cited by 28
Necrotizing myopathy induced by overexpression of interferon-? in transgenic mice
Shelton, G. D., Calcutt, N. A., Garrett, R. S., Gu, D., Sarvetnick, N., Campana, W. M., & Powell, H. C. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199902)22:2 · Cited by 24
Overexpression of the transcriptional coregulator Cited2 protects against glucocorticoid-induced atrophy of C2C12 myotubes
Tobimatsu, K., Noguchi, T., Hosooka, T., Sakai, M., Inagaki, K., Matsuki, Y., Hiramatsu, R., & Kasuga, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.062 · Cited by 23
Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells
Chamberlain, W., GONNELLA, P. A., Alamdari, N., Aversa, Z., & Hasselgren, P.-O. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-082 · Cited by 22
Protective Effect of Glutamine from Glucocorticoid-Induced Muscle Atrophy Occurs without Alterations in Circulating Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein Levels
Hickson, R. C., OEHLER, D. T., Byerly, R., & Unterman, T. G. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44157 · Cited by 21
Effect of the antiglucocorticoid RU38486 on protein metabolism in unweighted soleus muscle
Tischler, M. E. (1994) · Metabolism · doi:10.1016/0026-0495(94)90044-2 · Cited by 18
The anti-catabolic efficacy of insulin-like growth factor-I is enhanced by its early administration to rats receiving dexamethasone
Tomas, F. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1570089 · Cited by 17
Effect of the Beta-Agonist Clenbuterol on Dexamethasone-Induced Diaphragm Dysfunction in Rabbits
Jiang, T. X., Cairns, A., ROAD, J. D., & Wilcox, P. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.6.8970370 · Cited by 16
Gender-specific effects of dexamethasone treatment on rat diaphragm structure and function
Prezant, D. J., Karwa, M. L., Richner, B., Maggiore, D., Gentry, E. I., & Cahill, J. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.82.1.125 · Cited by 16
Myogenic Induction of Taurine Transporter Prevents Dexamethasone-Induced Muscle Atrophy
Uozumi, Y., Ito, T., Takahashi, K., Matsuda, T., Mohri, T., Kimura, Y., Fujio, Y., & Azuma, J. (2006) · Springer eBooks · doi:10.1007/978-0-387-33504-9_29 · Cited by 13
Creatine intake attenuates corticosteroid-induced impairment of voluntary running in hamsters
Campos, A. R., Serafini, L. N., Sobreira, C. F. D. R., Menezes, L. G., & Martínez, J. A. B. (2006) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h06-025 · Cited by 10
Prednisolone-Induced Muscle Dysfunction Is Caused More by Atrophy than by Altered Acetylcholine Receptor Expression
Shin, Y. S., Fink, H., Khiroya, R. H., et al. (2000) · Anesthesia & Analgesia · doi:10.1213/00000539-200008000-00017 · Cited by 10

Flagged first, then by citations

2 of the 157 references couldn’t be matched to a known paper.

Sorted by citations

Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., Martino, M. C. D., Newell-Price, J. D. C., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 694
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586
Understanding cachexia as a cancer metabolism syndrome
Porporato, P. E. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.3 · Cited by 562
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications
Ostrovidov, S., Hosseini, V., Ahadian, S., Fujie, T., Parthiban, S. P., Ramalingam, M., Bae, H., Kaji, H., & Khademhosseini, A. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0534 · Cited by 302
Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise
Kraemer, W. J., Ratamess, N. A., Hymer, W. C., Nindl, B. C., & Fragala, M. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00033 · Cited by 339

See all 705

Authors: Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P.
Affiliations: UCLouvain (BE)
Corresponding author: Thissen, J.P.
ORCID: Schakman, O.
Barbé, C.
Loumaye, A.
Venue: The International Journal of Biochemistry & Cell Biology
Publisher: Elsevier BV
Published: 2013-10
Volume: 45
Issue: 10
Pages: 2163-2172
ISSN: 1357-2725 (ISSN-L)
DOI: 10.1016/j.biocel.2013.05.036
OpenAlex: W2092885411
Cited by: 705
References: 157
Citations by year: 2026: 81 · 2025: 74 · 2024: 58 · 2023: 60 · 2022: 68 · 2021: 62 · 2020: 58 · 2019: 43 · 2018: 44 · 2017: 37 · 2016: 45 · 2015: 48 · 2014: 24 · 2013: 2
FWCI: 3.73
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The International Journal of Biochemistry & Cell Biology (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (submittedVersion)
Funders: Fund for Scientific Medical Research (Belgium)
National Fund for Scientific Research (Belgium)
Association Française contre les Myopathies (France)
Association Belge contre les Maladies neuro-musculaires
Fonds Spéciaux de Recherche (Université catholique de Louvain, Belgium)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords: glucocorticoid-induced muscle atrophy, skeletal muscle atrophy, muscle protein degradation, ubiquitin-proteasome system, lysosomal proteolysis, atrogenes, atrogin-1, MuRF1, FOXO, muscle protein synthesis, insulin-like growth factor I, myostatin, glucocorticoid-induced myopathy, cachexia, sepsis
MeSH terms: Animals, Glucocorticoids, Humans, Muscular Atrophy, Protein Biosynthesis, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glucocorticoid-induced skeletal muscle atrophy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks